Key Points
- CEO Richard Matros sold 200,000 Sabra Healthcare REIT shares at an average price of $20.83, generating approximately $4.17 million. The transaction reduced his holdings by 10.77% and was conducted under a pre-arranged Rule 10b5-1 trading plan.
- SBRA shares opened at $20.79, within a 52-week range of $17.17 to $22.77. The company’s latest quarterly results missed the EPS estimate but exceeded revenue expectations, with revenue rising 24.7% year over year.
- Sabra paid a quarterly dividend of $0.30 per share, equivalent to a 5.8% annualized yield. Analysts maintain a consensus “Hold” rating with an average target price of $22.17.
Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) CEO Richard Matros sold 200,000 shares of Sabra Healthcare REIT stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the transaction, the chief executive officer owned 1,657,686 shares of the company's stock, valued at $34,529,599.38. The trade was a 10.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Sabra Healthcare REIT Stock Performance
Shares of SBRA stock opened at $20.79 on Thursday. Sabra Healthcare REIT, Inc. has a 52-week low of $17.17 and a 52-week high of $22.77. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. The stock has a market cap of $5.31 billion, a PE ratio of 79.96, a price-to-earnings-growth ratio of 1.58 and a beta of 0.65. The business has a 50-day simple moving average of $20.68 and a 200-day simple moving average of $20.20.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.27). The company had revenue of $230.11 million for the quarter, compared to analyst estimates of $219.39 million. Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.The firm's revenue was up 24.7% on a year-over-year basis. During the same period last year, the business earned $0.38 earnings per share. On average, equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current year.
Sabra Healthcare REIT Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.8%. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 461.54%.
Wall Street Analysts Forecast Growth
SBRA has been the subject of several analyst reports. Citigroup reiterated a "market outperform" rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Mizuho set a $21.00 price target on shares of Sabra Healthcare REIT in a research report on Monday, August 31st. Wall Street Zen raised shares of Sabra Healthcare REIT from a "sell" rating to a "hold" rating in a report on Sunday, June 28th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Finally, UBS Group set a $25.00 target price on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $22.17.
Read Our Latest Report on SBRA
Institutional Inflows and Outflows
Several large investors have recently made changes to their positions in SBRA. Rothschild Investment LLC lifted its position in shares of Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 889 shares in the last quarter. Smartleaf Asset Management LLC increased its holdings in Sabra Healthcare REIT by 97.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust's stock worth $27,000 after acquiring an additional 714 shares in the last quarter. Versant Capital Management Inc increased its holdings in Sabra Healthcare REIT by 70.0% in the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust's stock worth $29,000 after acquiring an additional 603 shares in the last quarter. Danske Bank A S acquired a new position in Sabra Healthcare REIT during the third quarter worth $30,000. Finally, Larson Financial Group LLC raised its position in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust's stock worth $35,000 after acquiring an additional 553 shares during the period. 99.40% of the stock is owned by institutional investors and hedge funds.
Sabra Healthcare REIT Company Profile
(
Get Free Report)
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra's tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
